Uncertainty regarding exemption from infringement for studies after approval, or not required, by the US FDA
Pharm Pat Anal
.
2013 Jul;2(4):435-7.
doi: 10.4155/ppa.13.38.
Authors
Jonathan E Grossman
1
,
John P Hanish
Affiliation
1
Region North America, Fresenius Kabi USA, Three Corporate Drive, Lake Zurich, IL 60047, USA.
PMID:
24237118
DOI:
10.4155/ppa.13.38
No abstract available
MeSH terms
Drug Approval
Legislation, Drug
Patents as Topic* / legislation & jurisprudence
Uncertainty
United States
United States Food and Drug Administration